As of 2023, the antidepressant medicine sales in Italy stood at 12 US Dollars PPP per capita. Beginning in 2024, the forecast for the following years shows a modest but steady increase: 12.3 in 2024, 12.7 in 2025, 13 in 2026, 13.2 in 2027, and 13.4 in 2028. The year-on-year growth from 2023 to 2024 is approximately 2.5%, and the trend continues with slight annual increases, eventually leading to a CAGR of about 2.6% over this five-year forecast period.
Trends to watch for:
- Advancements in mental health awareness and treatments.
- Changes in healthcare policy affecting drug reimbursement and pricing.
- Innovations in pharmaceuticals that could impact demand and consumption.
- Evolving societal attitudes toward mental health and medication reliance.
